Which has preferable valuation and earnings, NNOX or ELMD?

Electromed has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nano-X Imaging $13.02M 3.89 -$75.02M -$2.14 N/A Electromed $73.78M 3.19 $5.15M $1.31 21.45

Is NNOX or ELMD more profitable?

Electromed has a net margin of 11.34% compared to Nano-X Imaging's net margin of -926.05%. Electromed's return on equity of 15.71% beat Nano-X Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -926.05% -116.93% -100.67% Electromed 11.34% 15.71% 13.37%

Does the media prefer NNOX or ELMD?

In the previous week, Nano-X Imaging had 1 more articles in the media than Electromed. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Electromed. Electromed's average media sentiment score of 1.84 beat Nano-X Imaging's score of 0.00 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Is NNOX or STIM more profitable?

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -926.05% -116.93% -100.67% Neuronetics -19.62% -125.11% -22.15%

Does the media prefer NNOX or PROF?

In the previous week, Nano-X Imaging had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Profound Medical. Nano-X Imaging's average media sentiment score of 0.00 equaled Profound Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NNOX or ZJYL?

Nano-X Imaging presently has a consensus target price of $4.33, indicating a potential upside of 572.88%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities analysts clearly believe Nano-X Imaging is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, NNOX or ZJYL?

Jin Medical International has higher revenue and earnings than Nano-X Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nano-X Imaging $13.02M 3.89 -$75.02M -$2.14 N/A Jin Medical International $20.69M 7.60 $1.19M N/A N/A

Is FOCL or NNOX more profitable?

FocalTherics has a net margin of -56.26% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets FocalTherics -56.26% -248.00% -44.69% Nano-X Imaging -926.05% -116.93% -100.67%

Nano-X Imaging (NNOX) Competitors

$0.64 -0.03 (-4.02%)

Closing price 04:00 PM Eastern

Extended Trading

$0.63 -0.01 (-1.37%)

As of 07:56 PM Eastern

Compare

NNOX vs. ELMD, STIM, PROF, ZJYL, and FOCL

Should you buy Nano-X Imaging stock or one of its competitors? Nano-X Imaging's main competitors and comparable companies include Electromed (ELMD), Neuronetics (STIM), Profound Medical (PROF), Jin Medical International (ZJYL), and FocalTherics (FOCL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Nano-X Imaging compare to Electromed?

Nano-X Imaging (NASDAQ:NNOX) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Nano-X Imaging has a beta of 1.28, indicating that its share price is 28% more volatile than the broader market. Comparatively, Electromed has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market.

Electromed has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	3.89	-$75.02M	-$2.14	N/A
Electromed	$73.78M	3.19	$5.15M	$1.31	21.45

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 10.5% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Nano-X Imaging had 1 more articles in the media than Electromed. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Electromed. Electromed's average media sentiment score of 1.84 beat Nano-X Imaging's score of 0.00 indicating that Electromed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Electromed	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Nano-X Imaging currently has a consensus target price of $4.33, indicating a potential upside of 572.88%. Electromed has a consensus target price of $43.75, indicating a potential upside of 55.67%. Given Nano-X Imaging's higher possible upside, research analysts plainly believe Nano-X Imaging is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Electromed has a net margin of 11.34% compared to Nano-X Imaging's net margin of -926.05%. Electromed's return on equity of 15.71% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats Nano-X Imaging on 12 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Neuronetics?

Nano-X Imaging (NASDAQ:NNOX) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

In the previous week, Nano-X Imaging had 2 more articles in the media than Neuronetics. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for Neuronetics. Nano-X Imaging's average media sentiment score of 0.00 equaled Neuronetics'average media sentiment score.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Neuronetics	Neutral

Neuronetics has higher revenue and earnings than Nano-X Imaging. Neuronetics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	3.89	-$75.02M	-$2.14	N/A
Neuronetics	$149.16M	1.14	-$39M	-$0.44	N/A

Nano-X Imaging has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market.

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Neuronetics	-19.62%	-125.11%	-22.15%

Nano-X Imaging currently has a consensus target price of $4.33, suggesting a potential upside of 572.88%. Neuronetics has a consensus target price of $4.67, suggesting a potential upside of 109.74%. Given Nano-X Imaging's higher possible upside, equities research analysts plainly believe Nano-X Imaging is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Neuronetics beats Nano-X Imaging on 9 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Profound Medical?

Nano-X Imaging (NASDAQ:NNOX) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Nano-X Imaging currently has a consensus target price of $4.33, suggesting a potential upside of 572.88%. Profound Medical has a consensus target price of $11.50, suggesting a potential upside of 97.12%. Given Nano-X Imaging's higher possible upside, research analysts plainly believe Nano-X Imaging is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Nano-X Imaging has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

In the previous week, Nano-X Imaging had 1 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Profound Medical. Nano-X Imaging's average media sentiment score of 0.00 equaled Profound Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profound Medical has higher revenue and earnings than Nano-X Imaging. Profound Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	3.89	-$75.02M	-$2.14	N/A
Profound Medical	$16.10M	13.25	-$42.57M	-$0.98	N/A

Profound Medical has a net margin of -171.57% compared to Nano-X Imaging's net margin of -926.05%. Profound Medical's return on equity of -63.03% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Profound Medical	-171.57%	-63.03%	-51.24%

Summary

Profound Medical beats Nano-X Imaging on 9 of the 15 factors compared between the two stocks.

How does Nano-X Imaging compare to Jin Medical International?

Nano-X Imaging (NASDAQ:NNOX) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

21.5% of Nano-X Imaging shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Nano-X Imaging presently has a consensus target price of $4.33, indicating a potential upside of 572.88%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities analysts clearly believe Nano-X Imaging is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has a net margin of 0.00% compared to Nano-X Imaging's net margin of -926.05%. Jin Medical International's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Jin Medical International	N/A	N/A	N/A

Nano-X Imaging has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.41, meaning that its stock price is 641% more volatile than the broader market.

In the previous week, Nano-X Imaging had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for Jin Medical International. Nano-X Imaging's average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Jin Medical International	Neutral

Jin Medical International has higher revenue and earnings than Nano-X Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	3.89	-$75.02M	-$2.14	N/A
Jin Medical International	$20.69M	7.60	$1.19M	N/A	N/A

Summary

Nano-X Imaging and Jin Medical International tied by winning 7 of the 14 factors compared between the two stocks.

How does Nano-X Imaging compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 10.1% of FocalTherics shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Nano-X Imaging had 2 more articles in the media than FocalTherics. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for FocalTherics. FocalTherics' average media sentiment score of 0.00 equaled Nano-X Imaging'saverage media sentiment score.

Company	Overall Sentiment
FocalTherics	Neutral
Nano-X Imaging	Neutral

FocalTherics has higher revenue and earnings than Nano-X Imaging. FocalTherics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.29	-$29.25M	-$1.03	N/A
Nano-X Imaging	$13.02M	3.89	-$75.02M	-$2.14	N/A

FocalTherics has a net margin of -56.26% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Nano-X Imaging	-926.05%	-116.93%	-100.67%

FocalTherics has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market.

FocalTherics presently has a consensus target price of $7.75, indicating a potential upside of 79.81%. Nano-X Imaging has a consensus target price of $4.33, indicating a potential upside of 572.88%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Nano-X Imaging beats FocalTherics on 8 of the 15 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$52.05M	$5.36B	$7.09B	$13.24B
Dividend Yield	N/A	1.80%	2.53%	15.89%
P/E Ratio	N/A	24.66	274.61	26.05
Price / Sales	3.84	41.72	600.51	90.03
Price / Cash	N/A	32.68	77.38	51.25
Price / Book	0.32	5.68	10.92	6.31
Net Income	-$75.02M	$152.11M	$3.50B	$361.43M
7 Day Performance	-0.70%	-2.01%	-2.11%	-1.67%
1 Month Performance	-16.77%	-5.42%	-6.34%	-3.94%
1 Year Performance	-83.23%	2.75%	8.81%	2.77%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	3.4511 of 5 stars	$0.64 -4.0%	$4.33 +581.7%	-82.1%	$52.05M	$13.02M	N/A	197	Gap Up
ELMD Electromed	3.324 of 5 stars	$27.00 +1.8%	$43.75 +62.0%	+16.1%	$221.96M	$73.78M	36.00	197	News Coverage Positive News
STIM Neuronetics	3.7573 of 5 stars	$2.85 -1.7%	$4.67 +63.7%	-18.4%	$220.97M	$149.16M	N/A	658	Positive News
PROF Profound Medical	1.7888 of 5 stars	$6.10 +4.1%	$11.50 +88.5%	+18.4%	$214.08M	$16.10M	N/A	162	Positive News High Trading Volume
ZJYL Jin Medical International	N/A	$2.07 +4.0%	N/A	-82.4%	$156.08M	$20.69M	N/A	273

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. ELMD, STIM, PROF, ZJYL, and FOCL

How does Nano-X Imaging compare to Electromed?

Summary

How does Nano-X Imaging compare to Neuronetics?

Summary

How does Nano-X Imaging compare to Profound Medical?

Summary

How does Nano-X Imaging compare to Jin Medical International?

Summary

How does Nano-X Imaging compare to FocalTherics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. ELMD, STIM, PROF, ZJYL, and FOCL

How does Nano-X Imaging compare to Electromed?

Which has more volatility and risk, NNOX or ELMD?

Which has preferable valuation and earnings, NNOX or ELMD?

Do insiders & institutionals hold more shares of NNOX or ELMD?

Does the media prefer NNOX or ELMD?

Do analysts prefer NNOX or ELMD?

Is NNOX or ELMD more profitable?

Summary

How does Nano-X Imaging compare to Neuronetics?

Does the media refer more to NNOX or STIM?

Which has preferable earnings and valuation, NNOX or STIM?

Which has more risk & volatility, NNOX or STIM?

Do insiders & institutionals have more ownership in NNOX or STIM?

Is NNOX or STIM more profitable?

Do analysts recommend NNOX or STIM?

Summary

How does Nano-X Imaging compare to Profound Medical?

Do analysts prefer NNOX or PROF?

Which has more risk & volatility, NNOX or PROF?

Does the media prefer NNOX or PROF?

Do insiders and institutionals have more ownership in NNOX or PROF?

Which has better earnings & valuation, NNOX or PROF?

Is NNOX or PROF more profitable?

Summary

How does Nano-X Imaging compare to Jin Medical International?

Do institutionals & insiders hold more shares of NNOX or ZJYL?

Do analysts recommend NNOX or ZJYL?

Is NNOX or ZJYL more profitable?

Which has more volatility and risk, NNOX or ZJYL?

Does the media prefer NNOX or ZJYL?

Which has higher valuation & earnings, NNOX or ZJYL?

Summary

How does Nano-X Imaging compare to FocalTherics?

Do institutionals and insiders believe in FOCL or NNOX?

Does the media prefer FOCL or NNOX?

Which has better earnings and valuation, FOCL or NNOX?

Is FOCL or NNOX more profitable?

Which has more risk & volatility, FOCL or NNOX?

Do analysts prefer FOCL or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools